← Evidence map

ArticleCancer research2024

ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1-Directed 4-1BB Activation.

Hui Yuwen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38501978